Presented positive interim data through 52 weeks and beyond for 4D-150 in wet AMD from PRISM Phase 1/2 clinical trial highlighting robust and ...

In a stunning revelation that will reshape the conversation around Elizabeth Holmes and her work at Theranos, one of the largest Specialty Labs in the Nation has confirmed that Holmes' diagnostic ...

Shares of Hims & Hers Health (NYSE: HIMS) sank 10.5% this week, according to data from S&P Global Market Intelligence. The ...

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the ...

Africa faces a critical medical supply crisis fueled by fragmented procurement systems, high costs, and counterfeit drugs.

Several rare disease patient populations received their first-ever FDA-approved drug since Rare Disease Day last year, ...

Q4 and full-year 2024 revenues surged to $1.1B and $3.8B respectively. Check out why I rate ONC stock as a Buy.

With a market cap of $394.2 billion, New Brunswick, New Jersey-based Johnson & Johnson (JNJ) is a global healthcare company ...

Praxis reported that its lead small molecule program failed a Phase 3 study on Friday morning, sending its stock price down ...

WASHINGTON (AP) — President Donald Trump plans to impose tariffs on Canada and Mexico starting Tuesday, in addition to ...

That puts them in precarious positions, where they need to raise cash to continue their research. But a failure to show ...

February 28, 2025 (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, ...